Skip to main content
OpenTrials

Clinical trial condition

Influenza, Human

Explore clinical trials studying Influenza, Human. Study availability and eligibility vary by location and protocol.

188 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Influenza, Human trial results

Completed

A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza

NCT05227001

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • Arizona Heart Rhythm Center Phoenix, Arizona, United States
  • Hope Research Institute Phoenix, Arizona, United States
  • The Pain Center of Arizona Phoenix, Arizona, United States
  • Diablo Clinical Research, Inc. Walnut Creek, California, United States
View all 24 locations
View Trial Details
Completed

A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults

NCT06431607

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Hialeah, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Chicago, Illinois, United States
View all 18 locations
View Trial Details
Completed

A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

NCT05446740

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Edegem, Belgium
  • GSK Investigational Site Ghent, Belgium
  • GSK Investigational Site Halifax, Nova Scotia, Canada
  • GSK Investigational Site Sherbrooke, Quebec, Canada
View Trial Details
Completed

A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

NCT06382311

Conditions
Animal Diseases, Bird Diseases, Infections, +7 more
Locations
  • GSK Investigational Site Anniston, Alabama, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Fort Collins, Colorado, United States
  • GSK Investigational Site Fort Myers, Florida, United States
View all 21 locations
View Trial Details
Completed

A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults

NCT06237049

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations
  • Orange County Research Center Lake Forest, California, United States
  • Orange County Research Center Tustin, California, United States
  • Diablo Clinical Research, Inc. Walnut Creek, California, United States
  • Clinical Research Consulting Milford, Connecticut, United States
View all 30 locations
View Trial Details
Completed

Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children .

NCT05779020

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • Instituto Auto Imune de Pesquisa e Educação Continuada - Real Hospital Português de Beneficência em Pernambuco (Site REC01) Recife, Pernambuco, Brazil
  • Centro Oncológico de Roraima - CECOR (Site BVB-01) Boa Vista, Roraima, Brazil
  • Centro de Pesquisas Clínicas da Universidade Federal de Sergipe (Site AJU01) Laranjeiras, Sergipe, Brazil
  • Hospital das Clínicas da Faculdade de Medicina Ribeirão Preto - USP (Site RAO 04) Ribeirão Preto, São Paulo, Brazil
View Trial Details
Completed

Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults

NCT05975840

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Anniston, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Tempe, Arizona, United States
  • GSK Investigational Site Chula Vista, California, United States
View all 20 locations
View Trial Details

Related conditions